Hyundai Pharmaceutical registered insect bites treatment 'Bumooly S' as OTC drug approved by the U.S. FDA
Hyundai Pharmaceutical registered insect bites treatment 'Bumooly S' as OTC drug approved by the U.S. FDA.
According to Hyundai Pharmaceutical, they completed U.S. FDA register of 'Bumooly S' and two OTC drugs including 'Moolpas-F Hyundai', and got credit for efficacy and safety.
Anti-inflammat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
